Human Embryonic Stem Cell-Derived Cardiomyocyte Therapy for Chronic Ischemic Left Ventricular Dysfunction (HECTOR)

General Information

Summary This clinical study will utilize a new cell therapy approach (Human embryonic stem cells derived cardiomyocytes or hESC-CMs) to improve survival and cardiac function in patients with chronic left ventricular dysfunction secondary to MI (Myocardial Infarction).
Description The phase I dose-escalation pilot study is intended as an initial safety assessment to establish the MTD prior to the phase II randomized, double-blinded, placebo-controlled study. An estimated eighteen (18) patients in phase I who are scheduled to undergo cardiac catheterization and have met all inclusion/exclusion criteria will be enrolled.
Clinical trials phase Phase 1
Start date (estimated) 2022-03-22
End date (estimated) 2025-10-31
Clinical feature
Label heart failure
Link http://purl.obolibrary.org/obo/SYMP_0000292

Administrative Information

NCT number NCT05068674
ICTRP weblink https://trialsearch.who.int/Trial2.aspx?TrialID=NCT05068674
Other study identifiers
Name 60978
Source weblink https://clinicaltrials.gov/ct2/show/study/NCT05068674
Regulatory body approval
Name Food and Drug Administration (FDA)
Country
United States
Public contact
Email joewu@stanford.edu
First name Joseph
Last name Wu
Phone (650) 736-2246
Fax (650) 736-0234
Street 265 Campus Drive, G1120B
Postcode 94305
City STANFORD
Country
United States
Sponsors Joseph C. Wu
Collaborators

Cells

Which differentiated cell type is used
Label cardiac muscle cell
Link http://purl.obolibrary.org/obo/CL_0000746
Description Cardiac muscle cells are striated muscle cells that are responsible for heart contraction. In mammals, the contractile fiber resembles those of skeletal muscle but are only one third as large in diameter, are richer in sarcoplasm, and contain centrally located instead of peripheral nuclei.; This class encompasses the muscle cells responsible for heart* contraction in both vertebrates and arthropods. The ultrastucture of a wide range of arthropod heart cells has been examined including spiders, horseshoe crabs, crustaceans (see Sherman, 1973 and refs therein) and insects (see Lehmacher et al (2012) and refs therein). According to these refs, the cells participating in heart contraction in all cases are transversely striated. Insects hearts additionally contain ostial cells, also transversely striated muscle cells, but which do not participate in heart contraction.

Recruitment

Recruitment Status Recruiting
Estimated number of participants 18